Year: 2006
Type: article
Abstract: The open-source software movement has successfully pioneered several strategies that might also be applicable in drug discovery and development. Munos considers the challenges involved, and proposes a model to harness the potential of open-source drug R&D. The low number of novel therapeutics approved by the US FDA in recent years continues to cause great concern about productivity and declining innovation. Can open-source drug research and development, using principles pioneered by the highly successful open-source software movement, help revive the industry?
Source: Nature Reviews Drug Discovery
DOI: 10.1038/nrd2131
Author: Bernard Munos
Institution: Eli Lilly (United States)
Language: English
Subfield: Computer Science Applications
Field: Computer Science
Domain: Physical Sciences
Open Access status: hybrid
OpenAlex ID: W2167692381
